Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pablo Manuel Bianculli, Lucile Bellier, Ignacio Olivera Mangado, Carlos Grau Pérez, Gustavo Mieres, Luis Lazarov, Audrey Petitjean, Hugo Dibarboure & Juan Guillermo Lopez. (2022) Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Guillermo M. Ruiz-Palacios, John H. Beigel, Maria Lourdes Guerrero, Lucile Bellier, Ramiro Tamayo, Patricia Cervantes, Fabián P. Alvarez, Arturo Galindo-Fraga, Felipe Aguilar-Ituarte & Juan Guillermo Lopez. (2020) Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Human Vaccines & Immunotherapeutics 16:4, pages 827-835.
Read now
Read now
Carla De Oliveira Bernardo, David Alejandro González-Chica & Nigel Stocks. (2020) Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database. Human Vaccines & Immunotherapeutics 16:3, pages 630-635.
Read now
Read now
Viviane Gresset-Bourgeois, Phillip S. Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierre Kazek-Duret, Iris De Bruijn & Sandrine I. Samson. (2018) Quadrivalent inactivated influenza vaccine (VaxigripTetra™). Expert Review of Vaccines 17:1, pages 1-11.
Read now
Read now
Articles from other publishers (16)
Tazio Vanni, Maria da Graça Salomão, Juliana Yukari Kodaira Viscondi, Patrícia Emilia Braga, Anderson da Silva, Roberta de Oliveira Piorelli, Joane do Prado Santos, Vera Lúcia Gattás, Maria Beatriz Bastos Lucchesi, Mayra Martho Moura de Oliveira, Marcelo Eiji Koike, Lucia M.A. Campos, Eduardo B. Coelho, Lily Yin Weckx, Amanda Nazareth Lara, Terezinha M. Paiva, Maria do Carmo S.T. Timenetsky & Alexander Roberto Precioso. (2023) A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults. Vaccine 41:22, pages 3454-3460.
Crossref
Crossref
Clara R. Warmath, Ismael R. Ortega-Sanchez, Lindsey M. Duca, Rachael M. Porter, Molly G. Usher, Joseph S. Bresee, Kathryn E. Lafond & William W. Davis. (2023) Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review. Value in Health 26:5, pages 768-779.
Crossref
Crossref
Ismael R. Ortega-Sanchez, Joshua A. Mott, Wanitchaya Kittikraisak, Viengphone Khanthamaly, Margaret McCarron, Soukphadeth Keokhonenang, Phonepaseuth Ounaphom, Chansay Pathammavong, Kongxay Phounphenghack, Panome Sayamoungkhoun, Phetsavanh Chanthavilay, Joseph Bresee & Chankham Tengbriacheu. (2021) Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People’s Democratic Republic. Vaccine 39:52, pages 7633-7645.
Crossref
Crossref
Liv Solvår Nymark, Alex Miller & Anna Vassall. (2021) Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses. PharmacoEconomics - Open 5:4, pages 587-603.
Crossref
Crossref
Juan Miguel Pascale, Danilo Franco, Raghavendra Devadiga, Rodrigo DeAntonio, Elidia Lourdes Dominguez-Salazar, Gael dos Santos & Patricia Juliao. (2021) Burden of Seasonal Influenza A and B in Panama from 2011 to 2017: An Observational Retrospective Database Study. Infectious Diseases and Therapy 10:4, pages 2465-2478.
Crossref
Crossref
Amine Amiche, Mine Durusu Tanriover, Lucile Bellier, Baris Ugur & Levent Akin. (2021) Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey. Value in Health Regional Issues 25, pages 15-22.
Crossref
Crossref
Álvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, Gabriel M. Aisenberg, Adrián Baranchuk, Eduardo Costa Duarte Barbosa, Gabriela Borrayo Sánchez, Bryce Alexander, Fernando Tomás Lanas Zanetti, Ricardo López Santi, Ana Girleza Múnera-Echeverri, Pablo Perel, Daniel Piskorz, Carlos Enrique Ruiz-Mori, Jorge Saucedo, Osiris Valdez, José Ramón González Juanatey, Daniel José Piñeiro, Fausto J. Pinto & Fernando Stuardo Wyss Quintana. (2021) Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Global Heart 16:1.
Crossref
Crossref
Analia Urueña, Paula Micone, Cecilia Magneres, Joaquin Mould-Quevedo & Norberto Giglio. (2021) Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina. Vaccines 9:4, pages 335.
Crossref
Crossref
Molly Sauer, Prarthana Vasudevan, Ankita Meghani, Karuna Luthra, Cristina Garcia, Maria Deloria Knoll & Lois Privor-Dumm. (2021) Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine 39:11, pages 1556-1564.
Crossref
Crossref
Pascal Crépey, Louis Boiron, Rafael Rodrigo Araujo, Juan Guillermo Lopez, Audrey Petitjean & Expedito José de Albuquerque Luna. (2020) Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model. BMC Public Health 20:1.
Crossref
Crossref
Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Miguel Betancourt-Cravioto, Myrna María Alfaro-Cortes, Roberto Isaac Bahena-González & Roberto Tapia-Conyer. (2020) Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children. BMC Infectious Diseases 20:1.
Crossref
Crossref
Gideon O Emukule, Fredrick Otiato, Bryan O Nyawanda, Nancy A Otieno, Caroline A Ochieng, Linus K Ndegwa, Peter Muturi, Godfrey Bigogo, Jennifer R Verani, Philip M Muthoka, Elizabeth Hunsperger & Sandra S Chaves. (2019) The Epidemiology and Burden of Influenza B/Victoria and B/Yamagata Lineages in Kenya, 2012–2016. Open Forum Infectious Diseases 6:10.
Crossref
Crossref
Angela Gentile, John Paget, Nancy Bellei, Juan Pablo Torres, Cynthia Vazquez, V. Alberto Laguna-Torres & Stanley Plotkin. (2019) Influenza in Latin America: A report from the Global Influenza Initiative (GII). Vaccine 37:20, pages 2670-2678.
Crossref
Crossref
Jane Barratt, Vyvyan Mishra & Megan Acton. (2019) Latin American Adult Immunisation Advocacy Summit: Overcoming regional barriers to adult vaccination. Aging Clinical and Experimental Research 31:3, pages 339-344.
Crossref
Crossref
Yun-Kyung Kim, Joon Young Song, Hyeongap Jang, Tae Hyun Kim, Heejo Koo, Lijoy Varghese & Euna Han. (2018) Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. PharmacoEconomics 36:12, pages 1475-1490.
Crossref
Crossref
Jan Hendriks, Raymond C.W. Hutubessy, Gary Grohmann, Guido Torelli, Martin Friede & Marie-Paule Kieny. (2018) Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability. Vaccine 36:28, pages 3993-3997.
Crossref
Crossref